(Total Views: 455)
Posted On: 05/24/2020 3:45:05 PM
Post# of 11803
For the old timers here-
Hypothetically, let’s say GenViro is FDA EUA and at some point FDA 510 approved.
It seems the company would be thrust into the limelight with the potential for rapid growth and/or M&A for the Covid-19 test kit platform. So let’s just say that DECN sells the Covid platform and it would likely be for $Bs.
Question: Would not the publicity and Covid-19 approval pave an expedited track for approval for GenUltimate TBG? And provide resources for GenChoice to be released from FDA purgatory? And expedite GenAccord?
Point is seems the door gets kicked open and off its hinges for DECN to run through and realize it’s quest on the diabetes stage.
I invested here for the diabetes business and think it becomes much more viable and accelerated. Thoughts?
Hypothetically, let’s say GenViro is FDA EUA and at some point FDA 510 approved.
It seems the company would be thrust into the limelight with the potential for rapid growth and/or M&A for the Covid-19 test kit platform. So let’s just say that DECN sells the Covid platform and it would likely be for $Bs.
Question: Would not the publicity and Covid-19 approval pave an expedited track for approval for GenUltimate TBG? And provide resources for GenChoice to be released from FDA purgatory? And expedite GenAccord?
Point is seems the door gets kicked open and off its hinges for DECN to run through and realize it’s quest on the diabetes stage.
I invested here for the diabetes business and think it becomes much more viable and accelerated. Thoughts?
(1)
(0)
